Metraipolis › archive › dc_4101c3dcf15e

Safety profiles of cyclosporine and tacrolimus in pregnancy: a pharmacovigilance analysis using the FDA Adverse Event Reporting System — Europe PMC PMID:42756046

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42756046
DOI
10.3389/fmed.2026.1917080
License (as archived)
solo-consultazione
Archived
2026-10-07T22:51:09.931Z
SHA-256 of the archived text
fffc70e14821e93f3631a66fa685ba59cc930a8ac699c2c5fc9fd1c4a58e290c
Stable URL of this page
https://metraipolis.com/documento/dc_4101c3dcf15e

How to cite

Safety profiles of cyclosporine and tacrolimus in pregnancy: a pharmacovigilance analysis using the FDA Adverse Event Reporting System — Europe PMC PMID:42756046 — Europe PMC (en), https://europepmc.org/article/MED/42756046 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4101c3dcf15e (Metraipolis archive dc_4101c3dcf15e, sha256 fffc70e14821e93f3631a66fa685ba59cc930a8ac699c2c5fc9fd1c4a58e290c)
BibTeX
@misc{dc4101c3dcf15e,
  title = {Safety profiles of cyclosporine and tacrolimus in pregnancy: a pharmacovigilance analysis using the FDA Adverse Event Reporting System — Europe PMC PMID:42756046},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42756046},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4101c3dcf15e; sha256 fffc70e14821e93f3631a66fa685ba59cc930a8ac699c2c5fc9fd1c4a58e290c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42756046. Agents can read the archived copy with the MCP tool read_document.